• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体抑制前列腺癌细胞中的神经内分泌转分化过程。

Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.

作者信息

Wright Michael E, Tsai Ming-Jer, Aebersold Ruedi

机构信息

Institute for Systems Biology, Seattle, Washington 98103, USA.

出版信息

Mol Endocrinol. 2003 Sep;17(9):1726-37. doi: 10.1210/me.2003-0031. Epub 2003 May 29.

DOI:10.1210/me.2003-0031
PMID:12775765
Abstract

Androgen-ablation therapy is an effective method for treating prostate cancer. However, prostate tumors that survive long-term androgen-ablation therapy are classified as androgen-independent as they proliferate in the absence of androgens, and they tend to be enriched for neuroendocrine (NE) cells. Androgen withdrawal causes androgen-dependent prostate cancer cells to adopt a pronounced NE phenotype, suggesting that androgen receptor (AR) represses an intrinsic NE transdifferentiation process in prostate cancer cells. In this report we show that short interfering RNA-induced AR silencing induced a NE phenotype that manifested itself in the growth of dendritic-like processes in both the androgen-dependent LNCaP and androgen-independent LNCaP-AI human prostate cancer cells. Western blot analysis revealed that neuronal-specific enolase, a marker of the neuronal lineage, was increased by AR knockdown in LNCaP cells. The expression levels of the neuronal-specific cytoskeletal proteins beta-tubulin III, nestin, and glial acidic fibrillary protein were also characterized in AR knockdown cells. Most interestingly, AR silencing induced beta-tubulin III expression in LNCaP cells, while AR knockdown increased glial acidic fibrillary protein levels in both LNCaP and LNCaP-AI cells. Lastly, AR silencing reduced the proliferative capacity of LNCaP and LNCaP-AI cells. Our data demonstrate that AR actively represses an intrinsic NE transdifferentiation process in androgen-responsive prostate cancer cells and suggest a potential link between AR inactivation and the increased frequency of NE cells in androgen-independent tumors.

摘要

雄激素剥夺疗法是治疗前列腺癌的一种有效方法。然而,长期接受雄激素剥夺疗法后仍存活的前列腺肿瘤被归类为雄激素非依赖性肿瘤,因为它们在没有雄激素的情况下仍能增殖,并且往往富含神经内分泌(NE)细胞。雄激素撤退会使雄激素依赖性前列腺癌细胞呈现出明显的NE表型,这表明雄激素受体(AR)抑制了前列腺癌细胞内源性的NE转分化过程。在本报告中,我们发现短发夹RNA诱导的AR沉默会诱导NE表型,这在雄激素依赖性LNCaP和雄激素非依赖性LNCaP-AI人前列腺癌细胞中表现为树突状样突起的生长。蛋白质印迹分析显示,神经元谱系标志物神经元特异性烯醇化酶在LNCaP细胞中因AR敲低而增加。在AR敲低的细胞中也对神经元特异性细胞骨架蛋白β-微管蛋白III、巢蛋白和胶质纤维酸性蛋白的表达水平进行了表征。最有趣的是,AR沉默在LNCaP细胞中诱导β-微管蛋白III表达,而AR敲低在LNCaP和LNCaP-AI细胞中均增加了胶质纤维酸性蛋白水平。最后,AR沉默降低了LNCaP和LNCaP-AI细胞的增殖能力。我们的数据表明,AR在雄激素反应性前列腺癌细胞中积极抑制内源性NE转分化过程,并提示AR失活与雄激素非依赖性肿瘤中NE细胞频率增加之间可能存在联系。

相似文献

1
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.雄激素受体抑制前列腺癌细胞中的神经内分泌转分化过程。
Mol Endocrinol. 2003 Sep;17(9):1726-37. doi: 10.1210/me.2003-0031. Epub 2003 May 29.
2
NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.NE-10神经内分泌癌促进去势小鼠体内LNCaP异种移植瘤的生长。
Cancer Res. 2004 Aug 1;64(15):5489-95. doi: 10.1158/0008-5472.CAN-03-3117.
3
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.雄激素剥夺诱导雄激素敏感的LNCaP细胞发生人前列腺上皮神经内分泌分化。
Endocr Relat Cancer. 2006 Mar;13(1):151-67. doi: 10.1677/erc.1.01043.
4
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.在LNCaP前列腺癌细胞进展过程中,白细胞介素-6经历了从与神经内分泌分化相关的生长抑制剂向伴随雄激素受体激活的刺激因子的转变。
Prostate. 2007 May 15;67(7):764-73. doi: 10.1002/pros.20553.
5
[The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells].[神经内分泌分化对前列腺癌细胞生长及雄激素受体表达的影响]
Zhonghua Wai Ke Za Zhi. 2004 Dec 7;42(23):1453-6.
6
Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.前列腺癌中的神经内分泌分化:聚焦于其病理生理机制和病理特征。
G Chir. 2010 Nov-Dec;31(11-12):568-74.
7
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.前列腺癌细胞中的雄激素受体信号传导与维生素D受体作用
Prostate. 2005 Sep 1;64(4):362-72. doi: 10.1002/pros.20251.
8
Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.与p21WAF1沉默相关的雄激素受体过表达可能是前列腺癌细胞系雄激素非依赖性及抗凋亡的原因。
Cancer Res. 2001 Oct 15;61(20):7544-51.
9
Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.血管活性肠肽通过蛋白激酶A依赖性细胞外信号调节激酶途径在前列腺癌LNCaP细胞中反式激活雄激素受体。
Mol Pharmacol. 2007 Jul;72(1):73-85. doi: 10.1124/mol.107.033894. Epub 2007 Apr 12.
10
Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.对PC-3 10[原激素转化酶-3 10的校正]人前列腺癌模型系统进行雄激素剥夺会诱导神经内分泌分化。
Cancer Res. 2000 Feb 1;60(3):741-8.

引用本文的文献

1
Neuroendocrine differentiation in prostate neoplasms.前列腺肿瘤中的神经内分泌分化
Pathologie (Heidelb). 2025 Aug 25. doi: 10.1007/s00292-025-01449-3.
2
[Neuroendocrine differentiation in prostate neoplasms. German version].[前列腺肿瘤中的神经内分泌分化。德文版]
Pathologie (Heidelb). 2025 Jul 16. doi: 10.1007/s00292-025-01447-5.
3
CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer.CYB561 支持去势抵抗性前列腺癌的神经内分泌表型。
PLoS One. 2024 May 13;19(5):e0300413. doi: 10.1371/journal.pone.0300413. eCollection 2024.
4
Case Series: "Silent" Spinal Epidural Metastases in Metastatic Castrate-Resistant Prostate Cancer.病例系列:转移性去势抵抗性前列腺癌中的“沉默”脊髓硬膜外转移
Case Rep Oncol. 2023 Nov 10;16(1):1370-1377. doi: 10.1159/000534685. eCollection 2023 Jan-Dec.
5
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies.PDE4D7 表达缺失促进雄激素非依赖性、神经内分泌分化和 DNA 修复改变:对治疗策略的影响。
Br J Cancer. 2023 Oct;129(9):1462-1476. doi: 10.1038/s41416-023-02417-5. Epub 2023 Sep 22.
6
Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance.用多西他赛靶向激素抵抗性乳腺癌细胞:探究抗药机制
Cancer Drug Resist. 2023 Feb 7;6(1):103-115. doi: 10.20517/cdr.2022.96. eCollection 2023.
7
Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer.动态评估血清嗜铬粒蛋白 A 联合醋酸阿比特龙治疗转移性去势抵抗性前列腺癌的疗效。
Prostate. 2023 May;83(7):649-655. doi: 10.1002/pros.24498. Epub 2023 Mar 16.
8
Histologic transformation in lung cancer: when one door shuts, another opens.肺癌中的组织学转化:当一扇门关闭时,另一扇门打开。
Ther Adv Med Oncol. 2022 Oct 14;14:17588359221130503. doi: 10.1177/17588359221130503. eCollection 2022.
9
Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.雄激素受体剪接变体促成前列腺癌中DNA修复的上调。
Cancers (Basel). 2022 Sep 13;14(18):4441. doi: 10.3390/cancers14184441.
10
Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance.神经纤毛蛋白-2 轴在调控神经内分泌样前列腺癌细胞分泌表型及其在治疗抵抗中的意义。
Cell Rep. 2022 Jul 19;40(3):111097. doi: 10.1016/j.celrep.2022.111097.